These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 35356854)

  • 1. N
    Ren Z; Hu Y; Sun J; Kang Y; Li G; Zhao H
    Bioengineered; 2022 Apr; 13(4):7963-7973. PubMed ID: 35356854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N
    Huang T; Cao L; Feng N; Xu B; Dong Y; Wang M
    Bioengineered; 2021 Dec; 12(2):10935-10944. PubMed ID: 34866525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AGAP2-AS1 promotes the assembly of m6A methyltransferases and activation of the IL6/STAT3 pathway by binding with WTAP in the carcinogenesis of gastric cancer.
    Nie K; Zheng Z; Li J; Chang Y; Deng Z; Huang W; Li X
    FASEB J; 2023 Dec; 37(12):e23302. PubMed ID: 37983949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. m
    Ji F; Lu Y; Chen S; Lin X; Yu Y; Zhu Y; Luo X
    Mol Ther Oncolytics; 2021 Sep; 22():574-581. PubMed ID: 34589576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIF-1α induced long noncoding RNA FOXD2-AS1 promotes the osteosarcoma through repressing p21.
    Ren Z; Hu Y; Li G; Kang Y; Liu Y; Zhao H
    Biomed Pharmacother; 2019 Sep; 117():109104. PubMed ID: 31228799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long noncoding RNA OIP5-AS1 accelerates CDK14 expression to promote osteosarcoma tumorigenesis via targeting miR-223.
    Dai J; Xu L; Hu X; Han G; Jiang H; Sun H; Zhu G; Tang X
    Biomed Pharmacother; 2018 Oct; 106():1441-1447. PubMed ID: 30119217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WTAP-mediated m
    Li ZX; Zheng ZQ; Yang PY; Lin L; Zhou GQ; Lv JW; Zhang LL; Chen F; Li YQ; Wu CF; Li F; Ma J; Liu N; Sun Y
    Cell Death Differ; 2022 Jun; 29(6):1137-1151. PubMed ID: 34999731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA FOXD2-AS1 knockdown inhibits the resistance of human osteosarcoma cells to cisplatin by inhibiting miR-143 expression.
    Zhang QQ; Xu SL; Ding C; Ma CC; Yuan TS; Hua CC; Wang XH
    Eur Rev Med Pharmacol Sci; 2021 Jan; 25(2):678-686. PubMed ID: 33577022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. m
    Bian Y; Xu S; Gao Z; Ding J; Li C; Cui Z; Sun H; Li J; Pu J; Wang K
    Cancer Lett; 2024 Aug; 596():217004. PubMed ID: 38838765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. WTAP promotes osteosarcoma tumorigenesis by repressing HMBOX1 expression in an m
    Chen S; Li Y; Zhi S; Ding Z; Wang W; Peng Y; Huang Y; Zheng R; Yu H; Wang J; Hu M; Miao J; Li J
    Cell Death Dis; 2020 Aug; 11(8):659. PubMed ID: 32814762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA MEG3 negatively modified osteosarcoma development through regulation of miR-361-5p and FoxM1.
    Shen B; Zhou N; Hu T; Zhao W; Wu D; Wang S
    J Cell Physiol; 2019 Aug; 234(8):13464-13480. PubMed ID: 30624782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long noncoding RNA FOXD2-AS1 promotes glioma malignancy and tumorigenesis via targeting miR-185-5p/CCND2 axis.
    Shen F; Chang H; Gao G; Zhang B; Li X; Jin B
    J Cell Biochem; 2019 Jun; 120(6):9324-9336. PubMed ID: 30520141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA DICER1-AS1 promotes the proliferation, invasion and autophagy of osteosarcoma cells via miR-30b/ATG5.
    Gu Z; Hou Z; Zheng L; Wang X; Wu L; Zhang C
    Biomed Pharmacother; 2018 Aug; 104():110-118. PubMed ID: 29772430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the FOXM1-regulated long noncoding RNA TUG1 in osteosarcoma.
    Li Y; Zhang T; Zhang Y; Zhao X; Wang W
    Cancer Sci; 2018 Oct; 109(10):3093-3104. PubMed ID: 30099814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The long non-coding RNA FOXD2-AS1 promotes bladder cancer progression and recurrence through a positive feedback loop with Akt and E2F1.
    Su F; He W; Chen C; Liu M; Liu H; Xue F; Bi J; Xu D; Zhao Y; Huang J; Lin T; Jiang C
    Cell Death Dis; 2018 Feb; 9(2):233. PubMed ID: 29445134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of the long noncoding RNA FOXD2-AS1 promotes carcinogenesis by epigenetically silencing EphB3 through EZH2 and LSD1, and predicts poor prognosis in gastric cancer.
    Xu TP; Wang WY; Ma P; Shuai Y; Zhao K; Wang YF; Li W; Xia R; Chen WM; Zhang EB; Shu YQ
    Oncogene; 2018 Sep; 37(36):5020-5036. PubMed ID: 29789713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA MCF2L-AS1 aggravates proliferation, invasion and glycolysis of colorectal cancer cells via the crosstalk with miR-874-3p/FOXM1 signaling axis.
    Zhang Z; Yang W; Li N; Chen X; Ma F; Yang J; Zhang Y; Chai X; Zhang B; Hou X; Luo S; Hua Y
    Carcinogenesis; 2021 Feb; 42(2):263-271. PubMed ID: 32860508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of FOXD2-AS1 enhances proliferation and impairs differentiation of glioma stem cells by activating the NOTCH pathway via TAF-1.
    Wang Y; Cheng Y; Yang Q; Kuang L; Liu G
    J Cell Mol Med; 2022 May; 26(9):2620-2632. PubMed ID: 35419917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long noncoding RNA SLC2A1-AS1 regulates aerobic glycolysis and progression in hepatocellular carcinoma via inhibiting the STAT3/FOXM1/GLUT1 pathway.
    Shang R; Wang M; Dai B; Du J; Wang J; Liu Z; Qu S; Yang X; Liu J; Xia C; Wang L; Wang D; Li Y
    Mol Oncol; 2020 Jun; 14(6):1381-1396. PubMed ID: 32174012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long noncoding RNA FOXD2-AS1 promotes glioma cell cycle progression and proliferation through the FOXD2-AS1/miR-31/CDK1 pathway.
    Wang J; Li B; Wang C; Luo Y; Zhao M; Chen P
    J Cell Biochem; 2019 Dec; 120(12):19784-19795. PubMed ID: 31347720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.